Global Urinary Tract Infection Treatment Market: North America strengthens Presence with Consistent Growth

Albany, USA, 2019-Oct-11 — /EPR Network/ —

Urinary tract infection (UTI) affects parts of urinary system including ureters, urethra, kidneys and bladder. UTI can be painful and can negatively effect kidney, producing serious health conditions. UTI targets renal disease patient easily as they stay long in hospitals and get exposed to non-sanitized urinary catheters during urological treatment. Global urinary tract infection treatment market was assessed to be around   ?US$5.9Bn in year 2018 and is anticipated to see growth at   ?3% CAGR for the forecast period 2019-2027. An intelligence report titled,” Urinary Tract Infection Treatment market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2027” is the source of all the stated insights. This report is the latest addition to Market Research Hub’s ever growing repository

E.Coli major cause

Quinolones segment in drugs class held major share of global urinary tract infection treatment market in 2018 and is anticipated to undergo rapid growth in coming years. E.Coli is the pathogen that dominated market in 2018 owing to increment in urinary tract infection affected geriatric population. According to WHO E.coli is the common cause of community-acquired UTI.

UTI is mostly prevalent in women population pertaining to various complications including pregnancy and menopause. General population is hesitant to seek medical help and this poses a challenge to UTI diagnosis and treatment. Unavailability of efficient therapies and increase in incidences of colonization by pathogens has steered the global urinary tract infection treatment market to generate opportunities for multiple business take holders including manufacturers and distributers.

Request Sample Report@

North America led the global urinary tract infection treatment market in 2018 and a further growth is expected in near future at moderate CAGR. Indulgence of key players in adoption of treatment strategies and early adoption of advanced diagnosis techniques have contributed in making North America lead. Asia Pacific and Europe also own significant market share.

Nabriva acquires Zavante

Major stake holders are expanding and merging to gain more penetration in global urinary tract infection treatment market. Nabriva therapeutics strengthened its potion in market by acquiring Zavante Therapeutics. Lupin launched generic Nitrofurantoin capsule to treat urinary tract infection caused by staphylococcus aureusm, E.coli, enterococci and Klebsiella. Other leading players profiled in global urinary tract infection treatment market are Allergan, Pfizer, Inc., Merck & Co., Inc., and GlaxoSmithKline plc.

Global urinary tract infection treatment market: Report Synopsis

Quantitative and qualitative assessment exhort intelligence and overarching report on the Global urinary tract infection treatment market. Further, the report thoroughly delineates various aspects of the market that will potentially have considerable influence on the development of the Global urinary tract infection treatment market. As such, those aspects incorporate drivers, trends, restraints, and opportunities. Furthermore, the report elucidates segregation of the market that provides an exhaustive analysis on urinary tract infection treatment.

Browse Complete Research Report with TOC@

An insightful and deep-dive assessment of the competitive assessment of the Global urinary tract infection treatment market pins hope on Porters’ Five Force Analysis. Accordingly, the Porters’ Five Force Analysis offers a pressing analysis on the potential strategies of the preeminent players in the Global urinary tract infection treatment market. In addition, the business strategies counts on company overview, product portfolio, SWOT analysis, key differentiation and recent development.

Global urinary tract infection treatment market: Research Methodology

Primary sources and secondary sources propel intelligence report on Global urinary tract infection treatment market that provide deep dive analysis on the market. As such, the report provides reliable and unbiased projections, and assessments which have palpable impact on the market size and historical data. Besides, the report also counts on primary sources which hinges upon in-depth and intelligent analysis from well-grounded and reliable experts, telephonic interview, and a thorough assessment from surveys and seasoned analyst.

Make An Enquiry About This Report @

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like healthcare market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us         

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)


Read Industry News at:


Matched content

Editor’s pick

Do NOT follow this link or you will be banned from the site!